CVS Health recently cited drug manufacturers’ contract pharmacy restrictions as one of the causes for a 19% year-over-year income decline [...] …
Year: 2024
A federal judge scheduled an April 2025 trial date for AstraZeneca’s lawsuit against Arkansas’ 340B contract pharmacy access law as [...] …
The 340B program continued to expand in 2023, exceeding $124 billion in wholesale acquisition cost (WAC) sales—up from $107 billion [...] …
This week will see major legislative action on up to four state 340B contract pharmacy access bills—including on two controversial [...] …
A new Senate draft drug shortages bill would offer bonus payments to hospitals that stockpile certain generic drugs and agree [...] …
The first fiscal year 2024 340B provider audit reports included no adverse findings for 19 organizations. The May 8 audit [...] …
A California health system’s lawsuit alleging “hundreds of millions” in overcharges by four drugmakers was recently released from required mediation [...] …
A key House of Representatives committee yesterday approved a bill to extend telehealth regulations that also would require pharmacy benefit [...] …
With less than two weeks remaining in the Missouri legislative session, two key house committees approved a 340B contract pharmacy [...] …
SPONSORED CONTENT
As we welcome the fresh energy of spring, now is the perfect time for 340B covered entities to conduct a thorough review and update of their 340B program. Ensuring your program’s compliance and efficiency is akin to spring cleaning—tidying up, organizing, and preparing for the year ahead. Below,
…